Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)


Open article in different language:  DE  |  FR  |  IT
Art. 62b Cooperation with the private sector 152

1 The Agency and the Fed­er­al Of­fice for Cus­toms and Bor­der Se­cur­ity (FO­CBS), after weigh­ing up the in­terests, are en­titled on a case-by-case basis to dis­close con­fid­en­tial data col­lec­ted in ac­cord­ance with this Act to the hold­er of an op­er­at­ing li­cence or of a mar­ket­ing au­thor­isa­tion for medi­cin­al products or to any per­son who places a med­ic­al device on the mar­ket, in­clud­ing sens­it­ive per­son­al data in ac­cord­ance with Art­icle 5 let­ter c num­ber 5 of the Data Pro­tec­tion Act of 25 Septem­ber 2020153, provided this meas­ure is re­garded as ne­ces­sary in or­der to un­cov­er or com­bat sus­pec­ted il­leg­al trad­ing in thera­peut­ic products.154

2 Per­son­al data re­lat­ing to pa­tients may not be dis­closed.

152 In­ser­ted by An­nex No 2 of the FD of 29 Sept. 2017 (Medicrime Con­ven­tion), in force since 1 Jan. 2019 (AS 2018 4771; BBl 2017 3135).

153 SR 235.1

154 Amended by An­nex 1 No II 74 of the Data Pro­tec­tion Act of 25 Sept. 2020, in force since 1 Sept. 2023 (AS 2022 491; BBl 2017 6941).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden